Kymera Therapeutics, Inc. (KYMR) ownership: Top institutional holder: FMR LLC ($974.49M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| FMR LLC | 11699950.00 | $974.49M | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 8657242.00 | $721.06M | 2026-03-31 |
| Avoro Capital Advisors LLC | 7474747.00 | $622.57M | 2026-03-31 |
| VANGUARD GROUP INC | 6267644.00 | $487.69M | 2025-12-31 |
| BVF INC/IL | 5502710.00 | $458.32M | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 5464997.00 | $455.18M | 2026-03-31 |
| BlackRock, Inc. | 5060876.00 | $421.52M | 2026-03-31 |
| Atlas Venture Life Science Advisors, LLC | 4578008.00 | $381.30M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-26 | |
| Sell | null | 2026-05-26 | |
| Sell | null | 2026-05-26 | |
| Sell | null | 2026-05-26 |
Back to KYMR overview · KYMR earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.